World Stem Cell Summit
  • About WSCS
    • About Us
    • Past Speakers
    • Annual Regenerative Medicine Essentials Course
    • 2023 Public Day
    • Symposium Intersection of RegMed & Healthspan
    • Effective Patient Advocacy
    • Regenerative Medicine & the Commercial Space Economy
    • Hot Topics in 2023 at World Stem Cell Summit
  • Partners/Sponsors
    • Partners/Sponsors
    • Sponsorship Opportunities
  • Upcoming Events
  • News & Media
    • News and Opinions
    • WSCS 2023 Photos
    • WSCS Video
  • Contact Us
Select Page
Avalon GloboCare Announces Execution of Purchase Agreement for Acquisition of SenlangBio in All Stock Transaction

Avalon GloboCare Announces Execution of Purchase Agreement for Acquisition of SenlangBio in All Stock Transaction

by admin | Jun 14, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

SenlangBio, a world-class cell therapy company, has developed a robust pipeline which includes 15 autologous and universal (“off-the-shelf”) CAR-T and CAR-γδT cell therapy candidates targeting hematologic malignancies and solid tumors   SenlangBio’s lead CAR-T...
Avalon GloboCare to Present at the Noble Capital Markets Investor Forum During the 16th Annual World Stem Cell Summit on June 17, 2021

Avalon GloboCare to Present at the Noble Capital Markets Investor Forum During the 16th Annual World Stem Cell Summit on June 17, 2021

by admin | Jun 11, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

FREEHOLD, N.J., June 11, 2021 (GLOBE NEWSWIRE) — Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, today announced that it will be presenting at the Noble Capital Markets...
Avalon GloboCare To Present Its S-Layer and QTY Code Breakthrough Technology Platforms at The Prestigious Annual World Stem Cell Summit

Avalon GloboCare To Present Its S-Layer and QTY Code Breakthrough Technology Platforms at The Prestigious Annual World Stem Cell Summit

by admin | Jun 8, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

FREEHOLD, N.J., June 08, 2021 (GLOBE NEWSWIRE) — Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, today announces that the company’s President and Chief Executive...
New Director Named for Mayo Clinic Center for Regenerative Medicine

New Director Named for Mayo Clinic Center for Regenerative Medicine

by admin | Jun 7, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

June 4, 2021 – By Susan Buckles – (link to article) – Julie Allickson, Ph.D., has been named the Michael S. and Mary Sue Shannon Director of Mayo Clinic’s Center for Regenerative Medicine and the Otto Bremer Trust Director, Biomanufacturing and...
Bone marrow stem cell transplants can benefit some Type 2 diabetes patients, study shows

Bone marrow stem cell transplants can benefit some Type 2 diabetes patients, study shows

by admin | Jun 3, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

Image caption: Research team from Vinmec Research Institute of Stem Cell and Gene Technology in Hanoi, Vietnam. Durham, NC — Type 2 diabetes patients who are not overweight and who have had the disorder for less than a decade can benefit from stromal stem cells...
Stem Cell and Regenerative Medicine Action Award Honorees to be Recognized During Virtual World Stem Cell Summit, June 18, 2021  #WSCS21

Stem Cell and Regenerative Medicine Action Award Honorees to be Recognized During Virtual World Stem Cell Summit, June 18, 2021 #WSCS21

by admin | Jun 2, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

2021 Honorees include Joseph P. Vacanti, MD, NFL Alumni Health, the Klein Family (Bob, Danielle and Rob),  Feng Zhang, PhD and the Global Immunization Action Network Team (GIANT) Winston Salem, NC  – June 2, 2021 – On June 18, 2021 at 7:00 PM EDT, ...
Page 138 of 179« First«...102030...136137138139140...150160170...»Last »

Recent Posts

  • Stem cell model replicates human amniotic sac development past two weeks
  • Infant becomes world’s first patient to undergo personalized gene-editing treatment
  • Biotech Tango dances away from preclinical work to extend cash runway, while Avalo lays out spending options
  • Embryonic macrophages found to control blood stem cell numbers in bone marrow
  • Federal appeals court sends CRISPR-Cas9 patent case back to patent office for reconsideration
  • The stem cell race for Parkinson’s disease: Recent studies show significant promise
World Stem Cell Summit Logo - White version
Copyright © 2025 Regenerative Medicine Foundation, All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow